NCT04126499View on ClinicalTrials.gov

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

May 8, 2020

Study Completion Date

May 8, 2020

Conditions
Severe Eosinophilic Asthma
Trial Locations (1)

Unknown

BIG PAC, Madrid

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY